Point72 Hong Kong LTD Harmony Biosciences Holdings, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$19.2 - $33.78 $189,542 - $333,476	9,872 New	9,872 $318,000
Q2 2022 Aug 15, 2022	SELL	$33.54 - $52.15 $203,621 - $316,602	-6,071 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$33.14 - $51.13 $201,192 - $310,410	6,071 New	6,071 $295,000
Q3 2021 Nov 15, 2021	SELL	$25.68 - $38.61 $9,604 - $14,440	-374 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$25.96 - $33.44 $9,709 - $12,506	374 New	374 $11,000

242

45.1M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.